» Articles » PMID: 28229087

Modeling Williams Syndrome with Induced Pluripotent Stem Cells

Overview
Date 2017 Feb 24
PMID 28229087
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The development of induced pluripotent stem cells (iPSCs) like never before has opened novel opportunity to study diseases in relevant cell types. In our recent study, Williams syndrome (WS), a rare genetic neurodevelopmental disorder, that is caused by hemizygous deletion of 25-28 genes on chromosome 7, is of interest because of its unique cognitive and social profiles. Little is known about haploinsufficiency effect of those deleted genes on molecular and cellular phenotypes at the neural level due to the lack of relevant human cellular model. Using the cellular reprogramming approach, we reported that WS iPSC-derived neural progenitor cells (NPCs) has increased apoptosis and therefore increased doubling time, which could be rescued by complementation of frizzled 9, one of the genes typically deleted in WS. Moreover, WS iPSC-derived CTIP2-positive pyramidal neurons exhibit morphologic alterations including longer total dendrites and increasing dendritic spine number. In addition, WS iPSC-derived neurons show an increase in calcium transient frequency and synchronized activity likely due to increased number of dendritic spines and synapses. Our work integrated cross-level data from genetics to behavior of WS individuals and revealed altered cellular phenotypes in WS human NPCs and neurons that could be validated in other model systems such as magnetic resonance imaging (MRI) in live subjects and postmortem brain tissues.

Citing Articles

Disruption of common ocular developmental pathways in patient-derived optic vesicle models of microphthalmia.

Eintracht J, Owen N, Harding P, Moosajee M Stem Cell Reports. 2024; 19(6):839-858.

PMID: 38821055 PMC: 11390689. DOI: 10.1016/j.stemcr.2024.05.001.


Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells.

Kot M, Neglur P, Pietraszewska A, Buzanska L Cells. 2022; 11(20).

PMID: 36291101 PMC: 9600461. DOI: 10.3390/cells11203234.


Williams syndrome: reduced orienting to other's eyes in a hypersocial phenotype.

Kleberg J, Riby D, Fawcett C, Bjorlin Avdic H, Frick M, Brocki K J Autism Dev Disord. 2022; 53(7):2786-2797.

PMID: 35445369 PMC: 9020553. DOI: 10.1007/s10803-022-05563-6.


Altered White Matter and microRNA Expression in a Murine Model Related to Williams Syndrome Suggests That miR-34b/c Affects Brain Development via and Modulation.

Grad M, Nir A, Levy G, Trangle S, Shapira G, Shomron N Cells. 2022; 11(1).

PMID: 35011720 PMC: 8750756. DOI: 10.3390/cells11010158.


Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering.

Gahwiler E, Motta S, Martin M, Nugraha B, Hoerstrup S, Emmert M Front Cell Dev Biol. 2021; 9:639699.

PMID: 34262897 PMC: 8273765. DOI: 10.3389/fcell.2021.639699.


References
1.
Morris C, Mervis C . Williams syndrome and related disorders. Annu Rev Genomics Hum Genet. 2001; 1:461-84. DOI: 10.1146/annurev.genom.1.1.461. View

2.
Chailangkarn T, Trujillo C, Freitas B, Hrvoj-Mihic B, Herai R, Yu D . A human neurodevelopmental model for Williams syndrome. Nature. 2016; 536(7616):338-43. PMC: 4995142. DOI: 10.1038/nature19067. View

3.
Kim D, Cheriyath V, Roy A, Cochran B . TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. Mol Cell Biol. 1998; 18(6):3310-20. PMC: 108912. DOI: 10.1128/MCB.18.6.3310. View

4.
Merla G, Howald C, Henrichsen C, Lyle R, Wyss C, Zabot M . Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes. Am J Hum Genet. 2006; 79(2):332-41. PMC: 1559497. DOI: 10.1086/506371. View

5.
Chapman R, Hesketh L . Behavioral phenotype of individuals with Down syndrome. Ment Retard Dev Disabil Res Rev. 2000; 6(2):84-95. DOI: 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P. View